{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:51:46Z","timestamp":1762271506246},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Thrasher Research Fund"},{"name":"National Institute of Allergy and Infectious Diseases"},{"name":"R01A171223"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.actatropica.2011.01.010","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:27:26Z","timestamp":1298107646000},"page":"142-151","source":"Crossref","is-referenced-by-count":27,"title":["Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum)"],"prefix":"10.1016","volume":"118","author":[{"given":"Weidong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Workineh","family":"Torben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2011.01.010_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-3024.2008.01091.x","article-title":"Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni","volume":"31","author":"Ahmad","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0010","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.vaccine.2009.02.096","article-title":"Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model","volume":"27","author":"Ahmad","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-009-1646-z","article-title":"Prime\u2013boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine","volume":"105","author":"Ahmad","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0020","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/j.ijid.2010.02.2266","article-title":"Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice","volume":"14","author":"Ahmad","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0025","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1521-4141(200109)31:9<2751::AID-IMMU2751>3.0.CO;2-4","article-title":"Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection","volume":"31","author":"Angeli","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"Bergquist","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0035","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature08160","article-title":"The genome of the blood fluke Schistosoma mansoni","volume":"460","author":"Berriman","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"TH-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0050","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1471-4906(03)00067-X","article-title":"Novel IL-12 family members shed light on the orchestration of Th1 responses","author":"Brombacher","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clinmicnews.2005.10.001","article-title":"Schistosomiasis: overview of the history, biology, clinicopathology, and laboratory diagnosis","volume":"27","author":"Coon","year":"2005","journal-title":"Clin. Microbiol. Newslett."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-3083.2001.00992.x","article-title":"Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiais","volume":"54","author":"El Ridi","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.vaccine.2008.11.039","article-title":"Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis","volume":"27","author":"El Ridi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.micinf.2010.04.012","article-title":"Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory-secretory candidate vaccine antigens","volume":"12","author":"El Ridi","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0090","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0095","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1127184","article-title":"Waterborne infectious diseases \u2013 could they be consigned to history?","volume":"313","author":"Fenwick","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1017\/S0031182009990400","article-title":"The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002\u20132008","volume":"136","author":"Fenwick","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0105","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1128\/IAI.68.10.6005-6011.2000","article-title":"Expression of Interleukin-9 leads to Th2 cytokine dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections","volume":"68","author":"Fallon","year":"2000","journal-title":"Intect. Immun."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.4049\/jimmunol.148.6.1792","article-title":"IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages","volume":"148","author":"Gazinelli","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0115","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazinelli","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0120","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.vaccine.2005.08.048","article-title":"Synergistic DNA-MVA prime\u2013boost vaccination regimes for malaria and tuberculosis","volume":"24","author":"Gilbert","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2007.10.054","article-title":"Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells","volume":"26","author":"Gl\u00fcck","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0130","first-page":"36","article-title":"Modulation of the oxidative burst of human neutrophils by pro- and anti-inflammatory cytokines","volume":"44","author":"Gougerot-Podicala","year":"1996","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"Harari","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0140","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1371\/journal.pntd.0000485","article-title":"Schistosomiasis in Africa: an emerging tragedy in our new global health decade","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0145","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.pt.2009.09.007","article-title":"An update on P-glycoprotein and drug resistance in Schistosoma mansoni","volume":"25","author":"James","year":"2009","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0155","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4049\/jimmunol.157.2.806","article-title":"Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni","volume":"157","author":"Jankovic","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0165","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.gt.3302799","article-title":"Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES","volume":"13","author":"Jia","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/CVI.00006-10","article-title":"Highly persistent and effective prime\/boost regimens against tuberculosis using a multi-valent MVA based tuberculosis vaccine molecularly adjuvanted with IL-15","volume":"17","author":"Kolibab","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0175","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1099\/vir.0.83384-0","article-title":"Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein\/DNA combination","volume":"89","author":"Koopman","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime\u2013boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0190","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0195","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/IAI.71.4.1643-1649.2003","article-title":"Effects of interleukin-8 and granulocyte colony-stimulating factor on priming and activation of bovine neutrophils","volume":"71","author":"Mitchell","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.parint.2004.01.007","article-title":"Research on calpain of Schistosoma japonicum as a vaccine candidate","volume":"53","author":"Ohta","year":"2004","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0205","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.vaccine.2004.10.042","article-title":"Establishment of Schistosoma japonicum calpain-specific mouse T cell hybridomas and identification of a T cell epitope that stimulates IFNgamma production","volume":"23","author":"Osada","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0210","first-page":"15","article-title":"Interleukin-6 is the main mediator of the interaction between monocytes and platelets in killing of Schistosoma mansoni","volume":"1","author":"Pancre","year":"1990","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-3024.1986.tb00866.x","article-title":"Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo","volume":"September","author":"Pearce","year":"1986","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/icb.1995.38","article-title":"IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils","volume":"73","author":"Reali","year":"1995","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0225","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/IAI.71.7.3844-3851.2003","article-title":"Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4","volume":"71","author":"Siddiqui","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0230","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/S0264-410X(03)00159-2","article-title":"Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation","volume":"21","author":"Siddiqui","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1051\/parasite\/2005121003","article-title":"Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants","volume":"12","author":"Siddiqui","year":"2005","journal-title":"Parasite"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0240","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2004.09.018","article-title":"Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon","volume":"23","author":"Siddiqui","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0250","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.smim.2007.10.008","article-title":"Th17 T cells: linking innate and adaptive immunity","volume":"19","author":"Stockinger","year":"2007","journal-title":"Sem. Immunol."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2009.07.581","article-title":"Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni","volume":"48","author":"Tallima","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0260","first-page":"184","article-title":"Theodor Bilharz (1825\u20131862): discoverer of schistosomiasis 5","volume":"48","author":"Tan","year":"2007","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0265","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1017\/S0031182009006350","article-title":"Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes","volume":"136","author":"Webster","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2011.01.010_bib0270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/651147","article-title":"Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine","volume":"201","author":"Zhang","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2011.01.010_bib0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-3024.2009.01181.x","article-title":"Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse","volume":"32","author":"Zhang","year":"2010","journal-title":"Parasite Immunol."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X11000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X11000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T08:33:23Z","timestamp":1685954003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X11000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0001706X11000258"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2011.01.010","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}